Mayer, E. L., Miller, K., Jhaveri, K. L., Yeh, R., Sakach, E., Prasad, V., Ferreira, D. V., Herszdorfer, P., Gong, L., Li, J., Bodei, L., Ulaner, G. A. (2025). RYZ101 (
            <sup>225</sup>
            Ac-DOTATATE) in patients with estrogen receptor-positive, human epidermal growth factor receptor 2–negative, locally advanced and unresectable, or metastatic breast cancer progressing after prior therapy: The phase 1b/2 TRACY-1 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps3184